Why Is PHIBRO ANIMAL HEALTH A (PAHC) Stock Up Today?
By the Top Tier Newswire AI Desk · August 28, 2026 at 9:47 AM ET · reviewed against 3 wire stories
PHIBRO ANIMAL HEALTH A (PAHC) is up +5.03% in the latest session. Our newswire has captured 3 stories on PAHC across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Phibro Animal Health (PAHC) stock rose 5.03% to $38.18 in early trading on August 27, 2026, driven by strong earnings results and updated guidance from the company. The stock opened at $36.36 and quickly surged to a session high of $38.22 shortly after the market opened. The move reflects positive investor reaction to record fiscal 2026 sales, a significant increase in adjusted EBITDA, and updated fiscal 2027 sales and earnings projections.
What Happened
Phibro Animal Health reported record fiscal 2026 sales and a sharp rise in adjusted EBITDA, driven by growth in its Animal Health and Mineral Nutrition segments. The company also announced updated guidance for fiscal 2027, projecting net sales of $1.55 billion to $1.6 billion. These figures exceeded analyst expectations, with adjusted EPS guidance of $3.41 to $3.59 and GAAP EPS of $2.98 to $3.22. The Q4 fiscal 2026 earnings call highlighted the integration of its Zoe acquisition and ongoing cost management efforts. The company also announced plans to close its Chicago Heights facility in summer 2027, which will affect approximately 100 employees.
What The Data Shows
The stock opened at $36.36 and climbed steadily, reaching a high of $38.22 within 10 minutes of the market open. The volume so far is 0.0M shares, which is 0.0x the 3-month average. Phibro has a market cap of $1.5 billion and a P/E ratio of 15.0, with trailing 12-month revenue up 17.1%. The stock is currently trading within its 52-week range of $28.25 to $60.08. On August 28, the stock printed eight fresh 52-week highs. Recent insider transactions include a $318,000 buy by director Corcoran E. Thomas on May 29, while former President Donald J. Trump sold between $1,001 and $15,000 of the stock on May 15.
What To Watch
Phibro Animal Health has no upcoming earnings date to note, but coverage of its recent earnings call and strategic updates is expected to expand over the next few days. Investors should monitor the breadth of analyst commentary and any follow-up on the company’s plant closure plans and regulatory developments in Brazil.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
PAHC · Aug 28 session (5-min) · +3.63% vs prior close · updated 8:44 PM ETAI sentiment, last 36h · averaged over 3 stories · 62/100 bullish
The headlines behind the move
Story flow · 3 stories on the wire, last 36h · hover or tap a dot for the headline
16d agoSeeking AlphaBULLISH 63Earnings
Phibro expects $1.55B-$1.6B fiscal 2027 net sales as it assumes minimal Brazil virginiamycin contribution
Phibro Animal Health (PAHC) Q4 FY2026 earnings call: record sales, EBITDA surge, FY2027 guidance, Brazil regulatory risk, and plant closure plans—read now.
16d agoSeeking AlphaNEUTRAL 50Earnings
Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call Transcript
Phibro Animal Health Corporation (PAHC) Q4 2026 Earnings Call August 27, 2026 9:00 AM EDTCompany ParticipantsGlenn David - Chief Financial OfficerDaniel...
16d agoYahoo FinanceBULLISH 73Earnings
Phibro Animal Health Q4 Earnings Call Highlights
Phibro Animal Health (NASDAQ:PAHC) reported record fiscal 2026 sales and a sharp increase in adjusted EBITDA, supported by growth in its Animal Health and Mineral Nutrition businesses, the integration of its acquired Zoetis medicated feed additive portfolio, and operational initiatives under its Phi
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →